Thrombolytic therapy for patients with myocardial infarction presenting after six hours
- 25 July 1992
- journal article
- Published by Elsevier in The Lancet
- Vol. 340 (8813) , 221-222
- https://doi.org/10.1016/0140-6736(92)90478-l
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Acute effects of delayed reperfusion on myocardial infarct shape and left ventricular volume: A potential mechanism of additional benefits from thrombolytic therapyJournal of the American College of Cardiology, 1991
- Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: Primary end point findings of the second mount sinai-new york university reperfusion trialJournal of the American College of Cardiology, 1989
- MECHANISM OF LATE BENEFIT IN ISIS-2The Lancet, 1988
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Intermittent Coronary Occlusion in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.Circulation, 1987
- Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarctionJournal of the American College of Cardiology, 1987
- Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage.Circulation, 1987
- Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: Overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trialsEuropean Heart Journal, 1985
- The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.Circulation, 1977